Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: | AdiraMedica Diclofenac Potassium 12.5 Fast |
Active Ingredient: | Diclofenac potassium 12.5mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | AdiraMedica Pty Limited |
Manufacturer: | Sunglow Lifescience Private Limited, Kanchipuram, India |
Product: | AdiraMedica Diclofenac Potassium 25 Fast |
Active Ingredient: | Diclofenac potassium 25mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | AdiraMedica Pty Limited |
Manufacturer: | Sunglow Lifescience Private Limited, Kanchipuram, India |
Product: | Boostrix |
Active Ingredients: | Diphtheria toxoid, adsorbed 2IU Pertactin 2.5mcg Pertussis filamentous haemagglutinin 8mcg Pertussis toxoid, adsorbed 8mcg Tetanus toxoid, adsorbed 20IU |
Dosage Form: | Suspension for injection |
New Zealand Sponsor: | GlaxoSmithKline NZ Limited |
Manufacturers: | GlaxoSmithKline Biologicals SA (Wave Nord), Rixensart, Belgium GlaxoSmithKline Biologicals (France), Saint-Amand-Les-Eaux, France |
Product: | Efudix |
Active Ingredient: | Fluorouracil 5% |
Dosage Form: | Topical cream |
New Zealand Sponsor: | iNova Pharmaceuticals (New Zealand) Limited |
Manufacturers: | Ensign Laboratories Pty Limited, Melbourne, Australia ICN Polfa Rzeszow SA, Rzeszow, Poland |
Dated this 2nd day of October 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).